Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development.
Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. Spagnolo P, et al. Among authors: karampitsakos t. Pharmacol Ther. 2021 Jun;222:107798. doi: 10.1016/j.pharmthera.2020.107798. Epub 2020 Dec 24. Pharmacol Ther. 2021. PMID: 33359599 Free PMC article. Review.
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations.
Bartziokas K, Papathanasiou E, Papaioannou AI, Papanikolaou I, Antonakis E, Makou I, Hillas G, Karampitsakos T, Papaioannou O, Dimakou K, Apollonatou V, Verykokou G, Papiris S, Bakakos P, Loukides S, Kostikas K. Bartziokas K, et al. Among authors: karampitsakos t. J Pers Med. 2023 Apr 19;13(4):686. doi: 10.3390/jpm13040686. J Pers Med. 2023. PMID: 37109072 Free PMC article.
Clinical features and outcomes of patients with myositis associated-interstitial lung disease.
Karampitsakos T, Tzilas V, Papaioannou O, Chrysikos S, Vasarmidi E, Juge PA, Vizirianaki S, Bibaki E, Reppa A, Sidiropoulos P, Katsaras M, Sotiropoulou V, Tsiri P, Koulousousa E, Theochari E, Tsirikos G, Christopoulos I, Malakounidou E, Zarkadi E, Sampsonas F, Hillas G, Karageorgas T, Daoussis D, Kalogeropoulou C, Dimakou K, Tzanakis N, Borie R, Dieudé P, Antoniou K, Crestani B, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Front Med (Lausanne). 2023 Jan 9;9:1096203. doi: 10.3389/fmed.2022.1096203. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698813 Free PMC article.
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.
Karampitsakos T, Papaioannou O, Tsiri P, Katsaras M, Katsimpris A, Kalogeropoulos AP, Malakounidou E, Zarkadi E, Tsirikos G, Georgiopoulou V, Sotiropoulou V, Koulousousa E, Chourpiliadi C, Matsioulas A, Lagadinou M, Sampsonas F, Akinosoglou K, Marangos M, Tzouvelekis A. Karampitsakos T, et al. Clin Microbiol Infect. 2023 Mar;29(3):372-378. doi: 10.1016/j.cmi.2022.10.015. Epub 2022 Oct 20. Clin Microbiol Infect. 2023. PMID: 36273769 Free PMC article.
Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou VE, Papanikolaou IC, Bibaki E, Tomos I, Lambiri I, Papaioannou O, Zarkadi E, Antonakis E, Pandi A, Malakounidou E, Sampsonas F, Makrodimitri S, Chrysikos S, Hillas G, Dimakou K, Tzanakis N, Sipsas NV, Antoniou K, Tzouvelekis A. Karampitsakos T, et al. Front Med (Lausanne). 2023 Jan 17;9:1083264. doi: 10.3389/fmed.2022.1083264. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36733935 Free PMC article.
Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou VE, Papanikolaou IC, Bibaki E, Tomos I, Lambiri I, Papaioannou O, Zarkadi E, Antonakis E, Pandi A, Malakounidou E, Sampsonas F, Makrodimitri S, Chrysikos S, Hillas G, Dimakou K, Tzanakis N, Sipsas NV, Antoniou K, Tzouvelekis A. Karampitsakos T, et al. Front Med (Lausanne). 2023 Apr 13;10:1194925. doi: 10.3389/fmed.2023.1194925. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37122328 Free PMC article.
Toll-like receptors in the pathogenesis of pulmonary fibrosis.
Karampitsakos T, Woolard T, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Eur J Pharmacol. 2017 Aug 5;808:35-43. doi: 10.1016/j.ejphar.2016.06.045. Epub 2016 Jun 27. Eur J Pharmacol. 2017. PMID: 27364757 Review.
Lung cancer in patients with idiopathic pulmonary fibrosis.
Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Pulm Pharmacol Ther. 2017. PMID: 28377145 Review.
Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.
Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D. Tzouvelekis A, et al. Among authors: karampitsakos t. Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29238708 Free PMC article.
99 results